Industry Blog
3 Testing Traps That Can Derail Your OTC Product Launch
Launching a new product is a high-stakes endeavor. You depend on testing data to validate performance, support claims, and satisfy regulators. Yet many companies stumble before they even get to
Photoallergy vs Phototoxicity Testing: Regulatory Guidelines & Best Practices in Photobiology Safety Assessment
In R&D, formulation, and for compliance teams working in cosmetics, personal care, or topical pharmaceutical products, understanding the differences between photoallergy and phototoxicity is essential to ensure product safety, meet
Why Cosmetic Brands Can’t Wait: The Asbestos-in-Talc and Fragrance Allergen Rules Under MoCRA Are Coming
Introduction: A New Era in U.S. Cosmetic Regulation The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) represents the most sweeping update to U.S. cosmetic legislation in decades. Among its
Understanding Dropping Point Testing for Sunscreen
When formulating sunscreen products, it’s essential to validate not only UV protection, such as SPF and broad-spectrum claims, but also thermal stability and performance under heat. Dropping Point testing is
Ensuring Consumer Safety: The Importance of Burkholderia cepacia Testing
Understanding Burkholderia cepacia: A Hidden Threat Burkholderia cepacia complex (BCC) comprises a group of Gram-negative, rod-shaped bacteria that are notorious for their opportunistic nature. These bacteria pose a significant health
Cosmetic Stability Testing: Why It Matters More Than Ever
Cosmetic Stability Testing: Why It Matters More Than Ever As consumers increasingly demand high-performing, long-lasting, and safe cosmetic products, stability testing has emerged as a cornerstone of modern product development.
Pharmaceutical Stability Testing: The Key to Product Safety and Regulatory Compliance
Pharmaceutical Stability Testing: The Key to Product Safety and Regulatory Compliance Pharmaceutical stability testing is more than a regulatory checkbox. It’s a critical scientific tool that determines whether a drug
Low-Level Contaminants in Pharmaceuticals: Navigating Risk, Regulation, and Detection Strategies
Low-Level Contaminants in Pharmaceuticals: Navigating Risk, Regulation, and Detection Strategies The pharmaceutical industry is under unprecedented scrutiny as regulators tighten restrictions on trace-level impurities in drug products. From nitrosamines to
Low-Level Contaminants in Cosmetics: A Growing Concern for Formulators and Manufacturers
Low-Level Contaminants in Cosmetics: A Growing Concern for Formulators and Manufacturers The presence of low-level contaminants in cosmetics and personal care products poses a significant challenge for modern formulators, R&D
“Free-Of” Claims in Product Labeling
The Rise of “Free-Of” Claims in Consumer Products In recent years, consumer product transparency demand has surged, driven by a growing awareness and concern for health and environmental sustainability. This